Role of the vitamin K-dependent protein periostin in predicting the effectiveness of an assisted reproductive technology program
Objective. To carry out a systematic analysis of the data available in the current literature on the role of the vitamin K-dependent protein periostin in the outcomes of an assisted reproductive technology (ART) program.Khechumyan L.R., Kalinina E.A., Donnikov A.E., Kulakova E.V., Ibragimova E.O.
Material and methods. The review includes the data of foreign and Russian articles found in Pubmed on this topic.
Results. Investigations conducted in recent years provide evidence that periostin exerts an effect on some important steps in the implantation process. Due to a wide range of its functions, periostin is expressed in various organs and tissues. The follicular fluid and serum level of periostin can be correlated with oocyte quality indicators, embryo development, and pregnancy and live birth rates. The paper gives the data of an investigation of the vitamin K-dependent protein periostin as a non-invasive marker to predict oocyte and embryo qualities and pregnancy onset rates.
Conclusion. The investigations performed confirm that the use of periostin is promising and relevant in predicting the effectiveness of an ART program.
Keywords
assisted reproductive technology
infertility
periostin (POSTN)
in vitro fertilization
vitamin K
mRNA expression
embryo implantation
References
1. Pfydey S., Shetty A., Hamilton M., Bhattacharya S., Maheshwary A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum. Reprod.Update. 2012; 18(5): 485-503.
2. Kalinina Ye.A., Ebzeyeva M.V., Kuzmichev L.N. Experience with mild superovulation regimens used in ovarian hyperstimulation syndrome risk group patients. Obstetrics and Gynecology/Akusherstvo i ginecologiya. 2010; 6: 60-4. (in Russian)
3. Kogan E.A., Kalinina E.A., Kuzmichev L.N., Duzheva E.V. Immunohistochemical study of endometrium in ART programs. Vestnik RUDN. 2009; 6: 98-104. (in Russian)
4. Kuzmichev L.N., Smolnikova V.Yu., Kalinina Ye.A., Dyuzheva Ye. V. The principles of complex evaluation and preparation of the endometrium in patients of assisted reproductive technology programs. Obstetrics and Gynecology/Akusherstvo i ginecologiya. 2010; (5): 32-6. (in Russian)
5. Smolnikova V.Yu., Kalinina E.A., Krasnoshchoka O.E., Donnikov A.E., Burmenskaya O.E., Trofimov D.Yu., Sukhikh G.T. Possibilities for noninvasive oocyte and embryo evaluation when implementing assisted reproductive technology programs for follicular-fluid growth factor mRNA expression. Obstetrics and Gynecology/Akusherstvo i ginecologiya. 2014; 9: 36-43. (in Russian)
6. Gunby J., Daya S. Assisted reproductive technologies (ART) in Canada: 2002 results from the Canadian ART Register. Fertil. Steril. 2006; 86(5): 1356-64.
7. Bromer J.G., Seli E. Assessment of embryo viability in assisted reproductive technology shortcomings of current approaches and the emerging role of metabolomics. Curr. Opin. Obstet. Gynecol. 2008; 20(3): 234-41.
8. Di Cello A., Rania E., Di Sanzo M., Alviggi E., Rienzi L., Morelli M., Zullo F. Periostin a new non-invasive parameter in addition to the morphologic criteria for evaluating oocyte/blastocyst quality and its impact on endometrial receptivity. Costanzo Department of Experimental and Clinical Medicine. Catanzaro, Italy; 2015.
9. Morelli M., Misaggi R., Di Cello A., Zuccala V., Costanzo F., Zullo F., Quaresima B. Tissue expression and serum levels of periostin during pregnancy: a new biomarker of embryo-endometrial cross talk at implantation. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014; 175: 140-4.
10. Coutu D.L., Wu J.H., Monette A., Rivard G.E., Blostein M.D., Galipeau J. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J. Biol. Chem. 2008; 283(26): 17991-8001.
11. Ferron M., Lacombe J., Germain A., Oury F., Karsenty G. GGCX and VKORC1 inhibit osteocalcin endocrine functions. J. Cell Biol. 2015; 208(6): 761-76.
12. Okano T. A New norizon in vitamin K research. Yakugaku Zasshi. 2016; 136(8): 1141-59.
13. Takeshita S., Kikuno R., Tezuka K., Amann E. Osteoblastspecific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 1993; 294(Pt 1): 271-8.
14. Snider P., Hinton R.B., Moreno-Rodriguez R.A., Wang J., Rogers R., Lindsley A. et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 2008; 102(7): 752-60.
15. Bao S., Ouyang G., Bai X., Huang Z., Ma C., Liu M. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004; 5(4): 329-39.
16. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y., Chang D.D. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002; 62(18): 5358-64.
17. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T. et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 2004; 24(9): 3992-4003.
18. Sasaki H., Dai M., Auclair D., Fukai I., Kiriyama M., Yamakawa Y. et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. 2001; 92(4): 843-8.
19. Baril P., Gangeswaran R., Mahon P.C., Caulee K., Kocher H.M., Harada T. et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and PI3k pathway. Oncogene. 2007; 26(14): 2082-94.
20. Li G., Jin R., Norris R.A. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis. 2010; 208(2): 358-65.
21. Li P., Oparil S., Feng W., Chen Y.F. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J. Appl. Physiol. 2004; 97(4): 1550-8.
22. Li G., Oparil S., Sanders J.M., Zhang L., Dai M., Chen L.B. et al. Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis. 2006; 188(2): 292-300.
23. Panduwawala C.P., Zhan X., Dissanayaka1 W.L., Samaranayake L.P., Jin L., Zhang C. In vivo periodontal tissue regeneration by periodontal ligament stem cells and endothelial cells in threedimensional cell sheet constructs. J. Periodontal Res. 2017; 52(3): 408-18.
24. Kong P., Christia P., Saxena A., Su Y., Frangogiannis N.G. Lack of specificity of Fibroblast Specific Protein (FSP) 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2013; 305(9): H1363-72.
25. Morra L., Moch H. Periostin expression and epithelial–mesenchymal transition in cancer: a review and an update. Virchows Arch. 2011; 459(5): 465-75.
26. Kudo Y., Siriwardena B.S., Hatano H., Ogawa I., Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol. Histopathol. 2007; 22(10): 1167-74.
27. Soltermann A. Epithelial-mesenchymal transition in non-small cell lung cancer. Pathologe. 2012; 33(Suppl. 2): 311-7.
28. Mamazhanov Z.K. Metastatic breast cancer (prognosis and treatment results): author's abstract. Diss. ... cand. med. sciences. Bishkek; 2007. (in Russian)
29. Malanchi I., Santamaria-Martínez A., Susanto E., Peng H., Lehr H.A., Delaloye J.F., Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011; 481(7379): 85-9.
30. Wang Z., Xiong S., Mao Y., Chen M., Ma X., Zhou X. et al. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis. J. Pathol. 2016; 239(4): 484-95.
31. Hamilton RG., MacGlashan D.W. Jr., Saini S.S. IgE antibody-specific activity in human allergic disease. Immunol. Res. 2010; 47(1-3): 273-84.
32. Suzaki I., Kawano S., Komiya K., Tanabe T., Akaba T., Asano K. et al. Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC. Respirology. 2017; 22(1): 93-100.
33. Hou J.J., Nie F.F., Li B.L., Zhao X., Qin Z.L., Ma Y.G., Li J.N. The expressions of periostin and the related factors during healing process of full-thickness cutaneous wound in rat. Zhongguo Wei Zhong Bing JiJiu Yi Xue. 2012;24(6): 334-7.
34. Polimeni G., Xiropaidis A.V., Wikesjo U.M. Biology and principles of periodontal wound healing/regeneration. Periodontol 2000. 2006; 41: 30-47.
35. Grzesik W.J., Narayanan A.S. Cementum and periodontal wound healing and regeneration. Crit. Rev. Oral Biol. Med. 2002; 13(6): 474-84.
36. Romanos G.E., Asnani K.P., Hingorani D., Deshmukh V.L. PERIOSTIN: role in formation and maintenance of dental tissues. J. Cell. Physiol. 2014; 229(1): 1-5.
37. Rios H.F., Ma D., Xie Y., Giannobile W.V., Bonewald L.F., Conway S.J., Feng J.Q. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J.. Periodontol. 2008;79(8): 1480-90.
38. Kruzynska-Frejtag A., Wang J., Maeda M., Rogers R., Krug E., Hoffman S. et al. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev. Dyn. 2004; 229(4): 857-68.
39. Yamaguchi Y., Ono J., Masuoka M., Ohta S., Izuhara K., Ikezawa Z. et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br. J. Dermatol. 2013; 168(4): 717-25.
40. Guerrot D., Dussaule J.C., Mael-Ainin M., Xu-Dubois Y.C., Rondeau E., Chatziantoniou C., Placier S. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012; 7(3): e31974.
41. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum. Reprod. Update. 2006; 12(6): 731-46.
42. Acosta A.A., Elberger L., Borghi M., Calamera J.C., Chemes H., Doncel G.F. et al. Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil. Steril. 2000; 73(4): 788-98.
43. Lessey B.A., Ilesanmi A.O., Lessey M.A., Riben M., Harris J.E., Chwalisz K. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am. J. Reprod. Immunol. Microbiol. 1996; 35(3): 195-204.
44. DeLoia J.A., Krasnow J.S., Brekosky J., Babaknia A., Julian J., Carson D.D. Regional specialization of the cell membrane-associated, polymorphic mucin (MUC1) in human uterine epithelia. Hum. Reprod. 1998; 13(10): 2902-9.
45. Ng Y.H., Zhu H., Leung P.C. Twist modulates human trophoblastic cell invasion via regulation of N-cadherin. Endocrinology. 2012; 153(2): 925-36.
46. Hiroi H., Momoeda M., Nakazawa F., Koizumi M., Tsutsumi R., Hosokawa Y. et al. Expression and regulation of periostin/OSF-2 gene in rat uterus and human endometrium. Endocr. J. 2008; 55(1): 183-9.
47. Rios H., Koushik S.V., Wang H., Wang J., Zhou H.M., Lindsley A. et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 2005; 25(24): 11131-44.
48. Kabir-Salmani M., Shiokawa S., Akimoto Y., Sakai K., Nagamatsu S., Sakai K. et al. Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology. 2003; 144(4): 1620-30.
Received 26.08.2016
Accepted 02.09.2016
About the Authors
Khechumyan Lusine Robertovna, graduate student of department of assisted reproductive technology in treatment of infertility, Research Center of Obstetrics,Gynecology, and Perinatology, Ministry of Health of Russia. 117997, Russia, Moscow, Ac. Oparina 4. Tel.: +74954382501. E-mail: khechumyan_l@mail.ru
Kalinina Elena Anatolievna, MD, Associate Professor, The chief of department of assisted reproductive technology in treatment of infertility, Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia. 117997, Russia, Moscow, Ac. Oparina 4. Tel.: +74954381341. E-mail: e_kalinina@oparina4.ru
Donnikov Andrew Evgenievich, PhD, Senior Researcher of molecul-genetical laboratory, Research Center of Obstetrics, Gynecology, and Perinatology,
Ministry of Health of Russia. 117997, Russia, Moscow, Ac. Oparina 4. Tel.: +74954381341. E-mail: a_donnikov@oparina4.ru
Kulakova Elena Vladimirovna, PhD, Senior Researcher of department of assisted reproductive technology in treatment of infertility, Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia. 117997, Russia, Moscow, Ac. Oparina 4. Tel.: +74954381341. E-mail: evkulakova@mail.ru
Ibragimova Espet Omarbekovna, graduate student of department of assisted reproductive technology in treatment of infertility, Research Center of Obstetrics,
Gynecology, and Perinatology, Ministry of Health of Russia. 117997, Russia, Moscow, Ac. Oparina 4. Tel.: +74954382501. E-mail: Espet2007@yandex.ru
For citations: Khechumyan L.R., Kalinina E.A., Donnikov A.E., Kulakova E.V.,
Ibragimova E.O. Role of the vitamin K-dependent protein periostin in predicting
the effectiveness of an assisted reproductive technology program.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (7): 28-32. (in Russian)
http://dx.doi.org/10.18565/aig.2017.7.28-32
Similar Articles
